J&J Tells 3rd Circ. No Price Impact In Talc Concealment Suit

Johnson & Johnson urged the Third Circuit on Tuesday to undo class certification of investor claims that the company inflated its stock price by failing to disclose cancer risks associated with...

Already a subscriber? Click here to view full article